BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 4935417)

  • 1. The protective effect of immunization in experimental E. coli pyelonephritis.
    Spencer AG; Fairhead A
    Clin Sci; 1971 Aug; 41(2):4P-5P. PubMed ID: 4935417
    [No Abstract]   [Full Text] [Related]  

  • 2. The cellular immune response in experimental Escherichia coli pyelonephritis in the rat.
    Spencer AG; Fairhead AP
    Nephron; 1972; 9(6):325-36. PubMed ID: 4570164
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of immunization with ethanol-soluble enterobacterial common antigen on in vivo bacterial clearance and hematogenous pyelonephritis.
    Frentz G; Domingue G
    Proc Soc Exp Biol Med; 1973 Jan; 142(1):246-52. PubMed ID: 4566760
    [No Abstract]   [Full Text] [Related]  

  • 4. Lack of protection against ascending Escherichia coli pyelonephritis in diabetic rats following immunization with purified lipopolysaccharide.
    Bryan LE; Schollaardt T; Pak CY; Kim CJ; Yoon JW
    Can J Microbiol; 1986 Dec; 32(12):967-9. PubMed ID: 3545411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental hematogenous pyelonephritis due to Escherichia coli in rabbits: the antibody response and its protective capacity.
    Kaijser B; Olling S
    J Infect Dis; 1973 Jul; 128(1):41-9. PubMed ID: 4577974
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunization against retrograde pyelonephritis. II. Prevention of retrograde Escherichia coli pyelonephritis with vaccines.
    Brooks SJ; Lyons JM; Braude AI
    Am J Pathol; 1974 Feb; 74(2):359-64. PubMed ID: 4590646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of immunization with Salmonella minnesota Re 595 against ascending Escherichia coli O6K13H1 pyelonephritis in rats.
    Larsson P; Kaijser B; Baltzer IM; Olling S
    Scand J Infect Dis Suppl; 1980; Suppl 24():220-3. PubMed ID: 7010560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection against experimental pyelonephritis by antibodies to pili.
    Silverblatt FJ; Weinstein R; Rene P
    Scand J Infect Dis Suppl; 1982; 33():79-82. PubMed ID: 6127805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental pyelonephritis in primates.
    Schoonees R; Neter E; Murphy GP
    J Med; 1972; 3(6):363-72. PubMed ID: 4203808
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunization against retrograde pyelonephritis. III. Vaccination against chronic pyelonephritis due to Escherichia coli.
    Brooks SJ; Lyons JM; Braude AI
    J Infect Dis; 1977 Nov; 136(5):633-9. PubMed ID: 335001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cellular kinetics of the immune response in pyelonephritis.
    Miller TE; North D
    J Lab Clin Med; 1971 Dec; 78(6):891-904. PubMed ID: 4943504
    [No Abstract]   [Full Text] [Related]  

  • 12. [The pathogenesis of pyelonephritis].
    Golokolosov AS
    Pediatriia; 1972 Oct; 51(10):78-82. PubMed ID: 4581200
    [No Abstract]   [Full Text] [Related]  

  • 13. Protective efficacy and immunogenicity of Escherichia coli K13 diphtheria toxoid conjugate against experimental ascending pyelonephritis.
    Kumar V; Ganguly Nk; Joshi K; Mittal R; Harjai K; Chhibber S; Sharma S
    Med Microbiol Immunol; 2005 Aug; 194(4):211-7. PubMed ID: 15909203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against ascending Escherichia coli pyelonephritis in rats and significance of local immunity.
    Kaijser B; Larsson P; Olling S
    Infect Immun; 1978 Apr; 20(1):78-81. PubMed ID: 352939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clofibric and ethacrynic acids prevent experimental pyelonephritis by Escherichia coli in mice.
    Balagué CE; de Ruiz CS; Rey R; de Duffard AM; Nader-Macías ME
    FEMS Immunol Med Microbiol; 2004 Nov; 42(3):313-9. PubMed ID: 15477045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological aspects of chronic pyelonephritis. Cellular immune response in chronic pyelonephritis.
    Szabó T; Fekete B; Petrányi G
    Acta Med Acad Sci Hung; 1974; 31(3-4):211-8. PubMed ID: 4620050
    [No Abstract]   [Full Text] [Related]  

  • 17. Protection against acute, ascending pyelonephritis caused by Escherichia coli in rats, using isolated capsular antigen conjugated to bovine serum albumin.
    Kaijser B; Larsson P; Olling S; Schneerson R
    Infect Immun; 1983 Jan; 39(1):142-6. PubMed ID: 6337094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gal-Gal pili vaccines prevent pyelonephritis by piliated Escherichia coli in a murine model. Single-component Gal-Gal pili vaccines prevent pyelonephritis by homologous and heterologous piliated E. coli strains.
    Pecha B; Low D; O'Hanley P
    J Clin Invest; 1989 Jun; 83(6):2102-8. PubMed ID: 2566625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigens of Escherichia coli, human immune response, and the pathogenesis of urinary tract infections.
    Hanson LA; Ahlstedt S; Fasth A; Jodal U; Kaijser B; Larsson P; Lindberg U; Olling S; Sohl-Akerlund A; Svanborg-Edén C
    J Infect Dis; 1977 Aug; 136 Suppl():S144-9. PubMed ID: 330773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipili antibody affords protection against experimental ascending pyelonephritis.
    Silverblatt FJ; Cohen LS
    J Clin Invest; 1979 Jul; 64(1):333-6. PubMed ID: 376560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.